New perspectives on treatment of gastrointestinal diseases: therapeutic potential of mesenchymal stromal cells
- 10 October 2022
- journal article
- review article
- Published by Saint Petersburg State University in Biological Communications
- Vol. 67 (3) , 217–230
Abstract
Mesenchymal stromal cells (MSCs) are a promising resource for cell therapy of different organs and systems, including the gastrointestinal tract (GIT). Therapeutic effect of MSC transplantation in GIT diseases may be partly due to their differentiation into various cellular components of the digestive tube. However, more significant is regulatory influence of MSCs on survival, proliferation, and differentiation of the gastric and intestinal epithelial cells, as well as their immunomodulatory, pro-angiogenic and antifibrotic effects. Data from experiments on animals and clinical trials indicate prospect of using MSCs in various diseases affecting any parts of GIT. However, effective and safe clinical use of MSCs requires an in-depth study of the mechanisms of their therapeutic effect, the development of optimal methods of administration, and risk assessment of adverse effects. This review analyzes MSC participation in regeneration of GIT and systematizes data on the potential of using MSCs in the treatment of gastroenterological diseases.Keywords
This publication has 99 references indexed in Scilit:
- Potential Role of Mesenchymal Stem Cells in Alleviating Intestinal Ischemia/Reperfusion ImpairmentPLOS ONE, 2013
- Multi-therapeutic effects of human adipose-derived mesenchymal stem cells on radiation-induced intestinal injuryCell Death & Disease, 2013
- Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissuesJournal of Cancer Research and Clinical Oncology, 2010
- Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epitheliumLaboratory Investigation, 2009
- Stem cells of intestinal epithelium. The mechanisms of survival and the role of microbiotaBiochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2009
- Fibroblastic Colony-Forming Unit Bone Marrow Cells Delay Progression to Gastric Dysplasia in aHelicobacterModel of Gastric TumorigenesisStem Cells, 2009
- Topical transplantation of mesenchymal stem cells accelerates gastric ulcer healing in ratsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic kneesOsteoarthritis and Cartilage, 2002
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991